Sigrid V. Carlsson, MD, PhD, MPH, suggests that, rather than abandoning PSA screening altogether, doctors should focus on patient selection for screening. She provides 5 key considerations for PSA screening, emphasizing risk-stratification and shared decision-making.
Read More
Sigrid V. Carlsson, MD, PhD, MPH, reviews recent guidelines regarding patient selection and protocols for prostate cancer active surveillance. She provides methods for counseling patients who would benefit from active surveillance, but experience anxiety from the prospect of foregoing aggressive therapy.
Read More
Sigrid V. Carlsson, MD, PhD, MPH, compares the National Comprehensive Cancer Network (NCCN) Prostate Cancer Early Detection v2.2018 guidelines to Memorial Sloan Kettering Cancer Center (MSKCC) recommendations for prostate cancer screening in terms of optimizing oncological benefits and reducing negative effects on quality of life.
Read More
Sigrid V. Carlsson, MD, PhD, MPH, reviews the history of PSA screening, from its discovery to the controversy related to United States Preventive Services Task Force (USPSTF) gradings during the current era. She also assesses the harms and benefits of PSA screening and responsible application of the PSA test.
Read More
Sigrid V. Carlsson, MD, PhD, MPH discusses the psychology, history, and practical application of shared decision making. She then provides recommendations for clinicians counseling patients deciding whether or not to undergo PSA screening and if they should go on active surveillance.
Read More
